Over- and Underuse of Proton Pump Inhibitors in Nursing Homes: A Multisite Longitudinal Cohort Study
Journal of the American Medical Directors Association · 2025
DOI: 10.1016/j.jamda.2024.105393 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Medical Directors Association, 2025. Verfasst von Nasir Wabe und 11 weiteren Autor:innen. Beteiligte Einrichtung: Australian Institute of Health Innovation, Macquarie University, Sydney, Australia. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Nursing Homes, Inappropriate Prescribing. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Themen: Langzeitpflege
Abstract (Originalsprache)
OBJECTIVES: Proton pump inhibitors (PPIs) are used to manage excess stomach acid production and provide gastroprotection from bleeding risk-increasing drugs (BRIDs). We aimed to determine the prevalence of potentially inappropriate PPI use in nursing homes and associated factors. DESIGN: Longitudinal cohort study using 8 years of electronic data. SETTING AND PARTICIPANTS: The study included 6439 permanent residents aged ≥65 years from 34 homes managed by 2 aged care providers in New South Wales. METHOD: Continuous PPI use (>12 weeks) in the absence of long-term BRID (>30 days) use was deemed inappropriate overuse whereas long-term BRID use without concomitant PPI for gastroprotection was classified as inappropriate underuse. Binary logistic regression was used to determine factors associated with PPI overuse. RESULTS: Fifty-four percent of residents (n = 3478) received a PPI, with a median duration of 46 weeks, whereas 58.5% (n = 3770) were long-term BRID users. Four of 5 PPI users (83.6%, n = 2906) used PPIs for >12 weeks, and after accounting for BRID use, the prevalence of inappropriate PPI overuse was 27.1% (n = 944). PPI overuse was 4 times more likely in residents in provider A compared with residents in provider B [odds ratio (OR) 4.08, 95% CI 2.73-6.09]. The prevalence of PPI underuse was 38.5% (n = 1452). CONCLUSIONS AND IMPLICATIONS: One in 4 PPI users exceeded the clinically recommended duration, whereas 2 in 5 long-term BRID users did not receive a PPI for gastroprotection. There is a pressing need for tailored interventions, such as medication reviews and deprescribing initiatives, to improve PPI prescribing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Australian Institute of Health Innovation, Macquarie University, Sydney, Australia.
- Australian Institute of Health Innovation, Macquarie University, Sydney, Australia. Electronic address: Isabelle.meulenbroeks@mq.edu.au.
- Australian Institute of Health Innovation, Macquarie University, Sydney, Australia; St Vincent's Clinical School, UNSW Medicine, UNSW Sydney, Sydney, NSW, Australia.
- Graduate School of Health, University of Technology Sydney, Sydney, Australia.
Förderung
- National Health and Medical Research Council
Zitieren
APA
Wabe, N., Urwin, R., Meulenbroeks, I., Seaman, K., Raban, M. Z., Neupane, S., Nguyen, A., Silva, S. M., Timothy, A., Batool, N., Pont, L., & Westbrook, J. I. (2025). Over- and Underuse of Proton Pump Inhibitors in Nursing Homes: A Multisite Longitudinal Cohort Study. Journal of the American Medical Directors Association. https://doi.org/10.1016/j.jamda.2024.105393
Vancouver
Wabe N, Urwin R, Meulenbroeks I, Seaman K, Raban MZ, Neupane S, et al. Over- and Underuse of Proton Pump Inhibitors in Nursing Homes: A Multisite Longitudinal Cohort Study. Journal of the American Medical Directors Association. 2025. doi:10.1016/j.jamda.2024.105393
BibTeX
@article{Wabe2025,
author = {Wabe, Nasir and Urwin, Rachel and Meulenbroeks, Isabelle and Seaman, Karla and Raban, Magdalena Z and Neupane, Sangita and Nguyen, Amy and Silva, Sandun M and Timothy, Andrea and Batool, Narjis and Pont, Lisa and Westbrook, Johanna I},
title = {Over- and Underuse of Proton Pump Inhibitors in Nursing Homes: A Multisite Longitudinal Cohort Study},
journal = {Journal of the American Medical Directors Association},
year = {2025},
doi = {10.1016/j.jamda.2024.105393}
}
EUVIMED